MAPK4 overexpression promotes tumor progression via noncanonical activation of AKT/mTOR signaling.
Wang W, Shen T, Dong B, Creighton CJ, Meng Y, Zhou W, Shi Q, Zhou H, Zhang Y, Moore DD, Yang F.
Wang W, et al. Among authors: zhou h, zhou w.
J Clin Invest. 2019 Mar 1;129(3):1015-1029. doi: 10.1172/JCI97712. Epub 2019 Jan 28.
J Clin Invest. 2019.
PMID: 30688659
Free PMC article.